PD-L1 expression on nonclassical monocytes reveals their origin and immunoregulatory function | Science Immunology
Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells | Scientific Reports
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies | Nature Immunology
Biomarkers of response to PD-1 pathway blockade | British Journal of Cancer
Early serum tumor marker dynamics predict progression-free and overall survival in single PD-1/PD-L1 inhibitor treated advanced NSCLC—A retrospective cohort study - Lung Cancer
Learning from PD-1 Resistance: New Combination Strategies: Trends in Molecular Medicine
Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review)
Frontiers | Tumor-Infiltrating PD-1hiCD8+-T-Cell Signature as an Effective Biomarker for Immune Checkpoint Inhibitor Therapy Response Across Multiple Cancers
Frontiers | The Diverse Function of PD-1/PD-L Pathway Beyond Cancer
Frontiers | PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
Effect of blocking PD-1 and PD-L1 on immune checkpoint and Treg-related... | Download Scientific Diagram
Anti-PDL-1 Antibody Treatment Reduces Expression of the Exhaustion Marker PD -1 in T Cells | Biocompare Antibody Review
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors | Molecular Cancer | Full Text
PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity
PD-1-high TILs: a predictive biomarker for ICB in lung cancer
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation - Pathology
The diverse functions of the PD1 inhibitory pathway | Nature Reviews Immunology
PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer | PNAS
Emerging biomarkers as predictors to anti-PD1/PD-L1 therapies in advanced melanoma | Immunotherapy
PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer - ScienceDirect
Role of PD-1 during effector CD8 T cell differentiation | PNAS
Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy | PNAS
Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses | Science
